SEC Form 4 · accession 0001091596-19-000005
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Emerson Jorden
Officer — CEO, CFO · Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 12:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $0.40 | Jan 1, 2019 | A | 125,000 | A | Jan 1, 2019 | Jan 1, 2026 | COMMON STOCK | 125,000 | 125,000 | D |